Clinical Trial Update: The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis.

View source ↗

Summary

This study explores using 18F-FDG and 68Ga-FAPI PET/CT imaging to evaluate response to conversion therapy in gastric cancer with peritoneal metastasis. The tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Peritoneal Metastasis

Drugs mentioned

• 18F-FDG (fluorodeoxyglucose F-18)
• 68Ga-FAPI (gallium-68 labeled fibroblast activation protein inhibitor)

Snippet

Sponsor: Ruijin Hospital | Conditions: Peritoneal Metastasis, Gastric Cancer | Status: RECRUITING